Boobalan Pachaiyappan
Stock Analyst at Roth Capital
(3.74)
Main Sectors:
Top Industries:
10 Stocks
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
RNA Avidity Biosciences | Initiates Coverage On: Buy | 62 | 46.97 | 32% | 1 | Sep 17, 2025 | |
RVPH Reviva Pharmaceutica... | Reiterates: Buy | 7 3 | n/a | n/a | 2 | Aug 18, 2025 | |
LGVN Longeveron | Maintains: Buy | 10 3 | 0.79 | 279.75% | 2 | Aug 15, 2025 | |
GANX Gain Therapeutics | Maintains: Buy | 7 6 | 1.92 | 212.5% | 3 | Aug 13, 2025 | |
CRVO CervoMed | Reiterates: Buy | 20 16 | 8.7 | 83.91% | 4 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 31 12 | 7.36 | 63.04% | 2 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Strong Buy | 92 116 | 106.79 | 8.62% | 2 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 12 9 | 3.51 | 156.41% | 2 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 12 11 | 4.18 | 163.16% | 2 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 29 | 6 | 383.33% | 1 | Dec 5, 2024 |